Consistent with this possibility, in several models of ASD such as a fragile X syndrome model (Fmr1−/−) of mice and valproate-treated mice, levels of the neurotrophic factor BDNF are increased28, 29. This evidence concerns the gene FMR1 and fragile X syndrome.